NEOGENOMICS INC — Director's Dealing 2021

Mar 5, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-02-23

Reporting Person: Brown Douglas Matthew (Chief Strategy Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	106989	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$28.33	2027-03-02	Common Stock (45017.0)		Direct

Footnotes

F1: On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.